What is the origin of the name Tangier disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Origin of the Name "Tangier Disease"

Tangier disease was named after Tangier Island, a small island in the Chesapeake Bay off the coast of Virginia, where the condition was first discovered nearly 40 years ago (from the 1999 publication date) in two siblings living on the island. 1

Historical Discovery

The disease derives its name directly from the geographic location where it was initially identified, following the common medical practice of naming rare genetic disorders after the place of discovery or the first affected family 2, 1. The two original siblings from Tangier Island presented with the characteristic features that would come to define this rare autosomal recessive disorder 1.

Why Geographic Naming Was Used

This naming convention was particularly appropriate for Tangier disease because:

  • Extreme rarity of the condition: To date, only approximately 100 patients have been diagnosed worldwide (about 35 cases in Japan and 109 cases outside Japan), making the initial discovery on a small island population particularly notable 2, 3

  • Distinctive presentation: The original patients likely presented with the pathognomonic large, yellow-orange tonsils that characterize the disease, making it a memorable and unique clinical entity worthy of eponymous designation 2, 3

  • Isolated population: Tangier Island's geographic isolation may have contributed to the concentration of this autosomal recessive trait, as consanguinity or founder effects in isolated populations can increase the likelihood of rare recessive disorders manifesting 1

The name has persisted in medical literature since its discovery, even after the molecular basis was elucidated in 1999 with the identification of mutations in the ABCA1 gene as the causative defect 1.

References

Research

Tangier disease: epidemiology, pathophysiology, and management.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2012

Research

Current Diagnosis and Management of Tangier Disease.

Journal of atherosclerosis and thrombosis, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.